Skip to main content
. 2020 Dec 17;107(1):134–142. doi: 10.3324/haematol.2020.266486

Table 5.

MURANO: best overall response and minimal residual disease status (ASO-PCR – peripheral blood) for patients who discontinued venetoclax due to adverse events.

graphic file with name 107134.tab5.jpg